Analytical and clinical evaluation of a heat shock SARS-CoV-2 detection method without RNA extraction for N and E genes RT-qPCR
•Heat shock based SARS-CoV-2 RT-PCR diagnosis has a sensitivity up to 89.4%.•For 100.000 copies/mL LoD, the sensitivity is as high as 98.6%.•Heat shock based SARS-CoV-2 RT-PCR is a reliable tool for low resources settings. The COVID-19 pandemic has caused significant supply shortages worldwide for S...
Saved in:
Published in | International journal of infectious diseases Vol. 109; pp. 315 - 320 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Canada
Elsevier Ltd
01.08.2021
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | •Heat shock based SARS-CoV-2 RT-PCR diagnosis has a sensitivity up to 89.4%.•For 100.000 copies/mL LoD, the sensitivity is as high as 98.6%.•Heat shock based SARS-CoV-2 RT-PCR is a reliable tool for low resources settings.
The COVID-19 pandemic has caused significant supply shortages worldwide for SARS-CoV-2 molecular diagnosis, like RNA extraction kits.
The aim of our study was to evaluate the clinical performance and analytical sensitivity of a simple SARS-CoV-2 diagnosis protocol based on heat shock without RNA extraction using both "CDC" (N gene) and "Charite" (E gene) RT-qPCR protocols.
1,036 nasopharyngeal samples, 543 of them SARS-CoV-2 positive, were analyzed. The heat shock method correctly identified 68.8% (232/337) and 89.4% (202/226) of SARS-CoV-2 positive samples for N gene and E gene, respectively. Analytical sensitivity was assessed for heat shock method using the CDC RT-qPCR protocol, obtaining sensitivity values of 98.6%, 93.3% and 84.8% for limit of detection of 100.000, 50.000 and 20.000 viral RNA copies/mL of sample.
Our findings show that a simple heat shock SARS-CoV-2 RT-qPCR diagnosis method without RNA extraction is a reliable alternative for potentially infectious SARS-CoV-2 positive patients at the time of testing. This affordable protocol can help overcome the cost and supply shortages for SARS-CoV-2 diagnosis, especially in developing countries. In Ecuador, it has been used already by laboratories in the public health system for more than 100.000 specimens. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors had contributed equally to this work. |
ISSN: | 1201-9712 1878-3511 |
DOI: | 10.1016/j.ijid.2021.06.038 |